2017
McCabe, C. Session 6: Reflections and Recommendations. Risk-Sharing Models to Advance Player Paradigms for Precision Medicine. Banff, Canada 28-29 June 2017.
McCabe, C. Session 2: Challenges for healthcare payers and developers in evaluating and funding precision medicines. Risk-Sharing Models to Advance Player Paradigms for Precision Medicine. Banff, Canada 28-29 June 2017
Caulfield, T., Moderator. Ethics Wrap Up. The Need to Accelerate Therapeutic Development, The New York Academy of Sciences. New York, New York. 20-21 June 2017.
Caulfield, T. Spinning Science: Fake News, Popular Culture and Our Health. PEW Research Center. Washington DC, USA. 27 April 2017.
Gold, R. Tiered Governance for Food and other Wicked Problems. The Convergent Innovation Webinar Series Pulse Program. Online Presentation. 27 April 2017.
Caulfield, T. Scienceploitation: The Marketing of SC Unproven Therapies. Conference Board of Canada. Toronto, Ontario. 26 April 2017.
Caulfield, T. Gene Editing: Law, Policy and Public Perceptions. 6th Annual Canadian Human and Statistical Genetics Meeting, CIHR, Quebec City, Quebec. 24 April 2017.
Gold, R. The Open Road of Open Science. Frankfurt Open Access/Open Science Symposium. Frankfurt, Germany. 24 April 2017.
McCabe, C. Measuring Value in Theory and the Real World. CADTH Symposium Ottawa. Ottawa, Canada 23-25 April 2017.
McCabe, C. Precision Medicine: Applying Theory to Practice for Value with Companion Diagnostics (CDx). CADTH Symposium Ottawa. Ottawa, Canada 23-25 April 2017.
McCabe, C. Quantifying and Presenting Uncertainty: A Workshop Based on the Revised (Fourth Edition) CADTH Guidelines for Economic Evaluation. CADTH Symposium Ottawa. Ottawa, Canada. 23-25 April 2017.
Gold, R. and Rouleau, G. Jump Starting Neurological Research and New Models of Collaboration. American Association for the Advancement of Science Annual Meeting. Boston, MA. 17 February 2017.
2016
Gold, R. The context of innovation. Innovation in Context Workshop. Montreal, Quebec. 9 November 2016.
Kimmelman, J. Can We Predict the Future of Genetics in Medicine? Tom Weinburger and Leslie Vermut endowed Lectureship. UCLA. Los Angeles, CA. 16 November 2016.
Bubela, T. Governance of Biomedical Research Commons: Lessons from the Humble Laboratory Mouse. MTA Workshop. Centre for Law and Genetics Genome. University of Tasmania, Tasmania, Australia. 9-10 November 2016.
Gold, R. Predatory IP Law and Canadian Innovation. The Social Costs of Innovation: Law, Society, and the Greater Good. Montreal, Quebec. 2 November 2016.
Bubela, T. Governance of Biomedical Research Commons: Lessons from the Humble Laboratory Mouse. Department of Social Science of Medicine, McGill University. Montreal, Quebec. 28 October 2016.
Bubela, T. Impact of intellectual property rights on reproducibility of science and academic-industry partnerships. IV Arnold Workshop “Reproducibility in Academia-Industry Partnerships. American Association for the Advancement of Science, Washington DC, USA. 24-25 October 2016
McCabe, C. Challenges in the evaluation of Precision medicine Technologies. Precision Medicine Policy Network Workshop. Vancouver, BC. 1 October 2016.
McCabe, C. Innovation costs: Economic challenges to sustainable implementation of cell and gene therapies. CCRM/Tlll and McCulloch Workshop. Whistler, BC. 1 October 2016
Bubela T. Lessons in university intellectual property management: The secret to survivin’ or a train bound for nowhere? Sixth Beedie Innovation Conference. Simon Fraser University, Vancouver, BC, Canada. 29 September 2016.
Gold, R. Current and Future Approaches to Governance: Open Science. OECD Workshop on Neurotechnology and Society: Strengthening Responsible Innovaiton in Brain Science. Washington DC, USA. 14 September 2016.
Kimmelman, J. Ethics of Early Phase Trials in Early Phase Neurological Drug Development. US National Academies of Sciences. Washington DC, USA. 13 September 2016.
Kimmelman, J. Regulation of Unproven Stem Cell-Based Interventions: The ISSCR Guidelines. FDA. Silver Springs, MD. 8 September 2016.
Caulfield, T. Is Gwyneth Really Wrong (and Why It Matters)? Celebrities, Science and Our Health. CAREB-ACCER 2015 National Conference and AGM. Vancouver, BC. 1 September 2016.
Kimmelman, J. Terms of Cooperation: Stem Cell Research and the ISSCR Guidelines. MHH. Hanover, Germany. 8 August 2016.
Bubela, T. Lessons in Governance of Biomedical Research Commons. AIRR 2016 Community Meeting: Progress in Standards, Tools and a Common Repository for Adaptive Immune-Receptor Repertoire Data. National Institutes of Health, Rockville, Maryland. 27-30 June 2016
Kimmelman, J. Accessibility of Trial evidence for Novel Neurological Drugs. Evidence Live 2016. Oxford, UK. 26 June 2016
McCabe, C. SMDM. SMDM Europe 16th Biennial European Conference. London, United Kingdom 12-14 June 2016.
McCabe, C. Developing Specialty Drugs for a value-based reimbursement environment. Canadian Society for Pharmaceutical Sciences Annual Conference. Vancouver, BC 1 June 2016.
McCabe, C. Conditional approval and drugs for rare diseases: Quicker may not be better. Canadian Pharmaceutical Sciences Association Conference. Vancouver, BC. 1, June 2016.
Bubela, T. Interdisciplinary Genomics Research. 2016 Congress of the Humanities and Social Sciences. Calgary, Alberta. 31 May 2016.
McCabe, C. Personalised Medicine and National Pharmacare. Witness to the House of Commons Standing committee on Health. Ottawa, ON. 29 May 2016.
Gold, R. Open Science, IP and Converging Technologies. Biotechnology, Nanotechnology and Converging Technologies Working Party of the Organisation for Economic Co-operation and Development. Washington D.C. USA. 26 May 2016.
McCabe, C. Introducing the Genome Canada Precision Medicine Policy Network. 2016 CADTH Symposium. Ottawa, ON. 14 April 2016.
McCabe, C. The Precision Medicine Policy Network. CADTH Symposium. Ottawa, Canada. 11 April 2016
Paulden, M., O’Mahony, J., and McCabe, C. The determinants of change in the cost-effectiveness threshold. 2016 CADTH Symposium. Ottawa, ON. 10-12 April 2016.
Akude, P., Mahjoub, R., Paulden, M., and McCabe, C. A framework for cost-effectiveness analysis of Personalized Medicine co-dependent technologies. 2016 CADTH Symposium. Ottawa, ON. 10-12 April 2016.
Paulden, M., O’Mahony, J., and McCabe, C. Decision rules for value-based reimbursement: Moving on from ‘net health benefit.’ 2016 CADTH Symposium. Ottawa, ON. 10-12 April 2016. (poster)
Bubela, T. Intellectual Asset Management Challenges for Precision Medicine. 2016 CADTH Symposium, Ottawa, Ontario, Canada. 11 April, 2016
Bubela, T. The Role of Universities in Innovation and Technology Transfer. Intellectual Property Rights and Innovation in the Fourth Industrial Revolution. Centre for International Governance Innovation (CIGI). Toronto, Ontario. 22-23 March 2016.
Bubela, T. Building the Medical Information Commons. Building the Medical Information Commons Advisory Committee Meeting. Baylor College of Medicine. Houston, Texas. 2-3 March 2016
Bubela, T. Universities as patent litigants: the case of NIPT. Commercialization of Non-invasive prenatal testing. Montreal, Quebec. 10-11 February, 2016.
McCabe, C. PACEOMICS: personalised and cost effective access to omics technologies. Genome on the Hill. Ottawa, ON. 1 February 2016.
2015
Kimmelman, J. The role of patients in the design and conduct of early phase trials. Lund, Sweden. 10 December 2015.
Caulfield, T. Genome editing: current developments and challenges. Toulouse, France. 3 December 2015.
Kimmelman, J. Research benefit evaluation in FIH trials: implications for gene editing in human embryos. CRISPR Summit D.C. Washington D.C., USA. 3 December 2015
Toews, M. Is there Anything Special about Rarity? Legal Issues Associated with Funding and Access to Rare Disease Treatment. PRISM Annual Meeting. Edmonton, AB. 30 October 2015
Mahjoub, R. Cost-Effectiveness of Genetic Diagnostic and Treatment Co-Dependent Technologies Under Uncertainty. University of Leeds. Leeds, UK. 21 October 2015.
Caulfield, T. The Role of the Media in Improving Health Care Outcomes. BC Provincial Renal Agency Annual Conference. Vancouver, BC. 2 October 2015.
Caulfield, T. Why All the Bunk? Public Trust, Pseudoscience and the Battle for Your Beliefs. La Ka Shing Knowledge Institute. Toronto, ON. 30 September 2015.
Caulfield, T. Celebrity Spin: What’s Driving (and How to Deal With) Health Myths & Pseudoscience? College of Physicians and Surgeons of British Columbia. Vancouver, BC. 25 September 2015.
Caulfield, T. Technology Push: Commercialization Pressure, Science Hype and Public Expectation, Assessing the Social and Ethical, Environmental and Economic Impacts of Emerging Technologies. Monash University. Melbourne, Australia. 9 September 2015.
Caulfield, T. Pressure, Commercialization and the Issue of Science Hype. University of Helsinki. Helsinki, Finland. 17 August 2015.
Mahjoub, R. Cost-effectiveness of Genetic Diagnostic and Treatment Co-dependent Technologies under Uncertainty. INFORMS Healthcare. Nashville, TN. 31 July 2015.
Van Zyl, C. Canadian Patent Litigation of Psychiatric Pharmaceuticals. International Congress of Law and Mental Health. Vienna, Austria. 23 July 2015.
Hey, S. and Barsanti-Innes, B. Multi-Modal Discordance and the Ontology of Biomarker Research. International Society of History, Philosophy and Social Studies of Biology. Montreal, QC. 6 July 2015.
Caulfield, T. The Clinic of the Future: Revolution Free (I Hope So!) Oxford University. Oxford, UK. 23-25 June 2015.
Caulfield, T. Bioethics, Technology and the Body: Who Owns What?” le Corps en Question(s)2 the Body in Question(s). University of Alberta Museums. Edmonton, AB. 19 June 2015.
Gold, R. Changing the Landscape of Gene Patents: Social Science at Work. Genome Alberta Mini Symposium on ‘Genomics and Personalized Health: health policy and barriers to adoption’. Edmonton, AB. 18 June 2015.
Mahjoub, R. Cost-effectiveness of Genetic Diagnostic and Treatment Co-dependent Technologies under Uncertainty. CORS/INFORMS. Montreal, QC. 17 June 2015.
Caulfield, T. When Celebrities and Culture Clash! Edmonton Community Foundation. Edmonton, AB. 16 June 2015.
Caulfield, T. Biomedicine, Commercialization and the Challenge of Science Hype. University of Heidelberg. Heidelberg, Germany. 11 June 2015.
Bubela, T. Intellectual Property Law and Technology Commercialization. Case studies used to teach one week intensive course for U of A MBA students. 8-12 June 2015.
Toews, M. Implications of Commercialization Pressure in Genomic Research. Research Ethics Group, Alberta Innovates Health Solutions. Edmonton, AB. 5 June 2015.
Caulfield, T. Finding Truth in a sea of myth and misinformation. Dietitians of Canada National Conference. Quebec City, QC. 4-6 June 2015.
Bubela, T. Mining Data Mountain: Data-sharing Principles and Practices [invited speaker]. Community Meeting: Analysis, Management and Sharing of Antigen Receptor Repertoire Sequence Data. 31 May 2015.
Caulfield, T. Celebrities and Science Spin. Canadian Association of Emergency Physicians Annual Conference. Edmonton, AB. 30 May – 3 June 2015.
Caulfield, T. Nutrigenetics Translation: From Genetic Variation to Dietary Intervention. Canadian Nutrition Society Annual Conference. Winnipeg, MB. 28-30 May 2015.
Caulfield, T. The Forces that Twist Health Science (and How to Get to the Truth). 2015 Stirling Lecture, Workers Compensation Board. Edmonton, AB. 26-27 May 2015.
Mahjoub, R. Evaluation of a Pharmaceutical Risk-sharing Agreement when Patients are Screened for the Probability of Success. ISPOR 20th Annual International Meeting. Philadelphia, PA. 16-20 May 2015.
Paulden, M. Should Decision Makers Embrace ‘Non-constant’ Discounting? ISPOR 20th Annual International Meeting. Philadelphia, PA. 16-20 May 2015. (Poster.)
Paulden, M. Incorporating Social Values into Cost-effectiveness Analysis. ISPOR 20th Annual International Meeting. Philadelphia, PA. 16-20 May 2015. (Two presentations.)
Akude, P. Advancing Methods of HTA: Optimising Monitoring Tests to Meet Value Targets. ISPOR 20th Annual International Meeting. Philadelphia, PA. 16-20 May 2015.
Caulfield, T. The Forces That Twist Science. Fifth International Congress on Bone Conduction Hearing and Related Technologies. Lake Louise, AB. 20-23 May 2015.
Mahjoub, R. A Supply Chain Design and Optimization for Non-reactor-based Production of Tc-99m Medical Imaging Isotope. POMS. Washington, DC. 11 May 2015. (Poster.)
Caulfield, T. Genetic Modifications in Humans: The Scientific Methods, Medical Applications and Ethical Implications. ISSCR Webinar. 8 May 2015.
Caulfield, T. When Celebrity Culture and Science Clash. Centre for Inquiry. Ottawa, ON. 6 May 2015.
Caulfield, T. Defining Trust in Science and the Factors that Erode It” Does the Public Trust Science? National Academy of Sciences. Washington, DC. 5 May 2015.
Caulfield, T. Keynote: Is Gwyneth Really Wrong (and Why It Matters)? Celebrities, Science and Our Health. CAREB-ACCER 2015 National Conference and AGM. Vancouver, BC. 1-2 May 2015.
McCabe, C. and Bubela, T. Translational Research for Reimbursement: The Value Engineered Translation Framework. BioCanRx Board Meeting. Ottawa, ON. 1 May 2015.
Caulfield, T. Debunking Health Myths. University of Alberta Alumini, President’s Farewell Reception. Hong Kong. 28 April 2015.
Bubela, T. The Global Landscape of Cellular Immunotherapy Clinical Trials. Canadian GE3LS and Health Services and Policy Research Conference. Vancouver, BC. 18-21 April 2015.
Bubela, T. Co-organiser and Chair: Session 6 – Innovating Molecular Diagnostic Technologies for the Clinic. Canadian GE3LS and Health Services and Policy Research Conference. Vancouver, BC. 21 April 2015.
Bubela, T. Headroom and Value in Biotherapeutics R&D [invited speaker]. Canadian GE3LS and Health Services and Policy Research Conference. Vancouver, BC. 20 April 2015.
Toews, M. ‘Marginally Scientific?’ Genetic Testing of Children and Adolescents for Lifestyle and Health Promotion. Vancouver, BC. 18-21 April 2015. (Poster)
Caulfield, T. Academic Research in Genomics: Facing the Translation and Commercialization Policy Pressure. Canadian GE3LS and Health Services & Policy Research Conference: Integrated Approaches to Challenges in the Genomics Era. Vancouver, BC. 18-21 April 2015.
Caulfield, T. When Celebrity Culture and Science Clash. Centre for Inquiry. Toronto, ON. 15 April 2015.
McCabe, C. End of Life Premiums in Reimbursement Decision Making. CADTH Symposium. Saskatoon, Canada 12-14 April 2015.
McCabe, C. Patient Reported Outcomes and Health Care Reimbursement. CADTH Symposium. Saskatoon, Canada 12-14 April 2015.
McCabe, C. Building a Bridge between HTA and Procurement. CADTH Symposium. Saskatoon, Canada 12-14 April 2015.
McCabe, C. CADTH Update of the Guidelines for Economic Evaluation of Health Technologies. CADTH Symposium. Saskatoon, Canada 12-14 April 2015.
Paulden, M. Should decision makers embrace ‘non-constant’ discounting? Saskatoon, SK. 12-14 April 2015. (Podium)
Paulden, M. Transforming the Cost-effectiveness Threshold into a ‘Value Threshold’: Initial Findings from a Simulation Model. Saskatoon, SK. 12-14 April 2015. (Poster and workshop)
Wallner, K. Investigating the Expected Net Benefit of Sampling: the PRESSURE 2 Trial on the Prevention of New Pressure Ulcers. Saskatoon, SK. 12-14 April 2015. (Poster)
Caulfield, T. The Limits of Personalized Medicine. CIHR Best Brains Exchange: Canada as a Leader in the Development and Deployment of Precision/Personalized Medicine. Ottawa, ON. Mar 2015.
Toews, M. Genetic Research Under Pressure: Implications of the Drive to Commercialize Research Findings. Biological Speaker Series. MacEwan University. Edmonton, AB. Mar 2015.
Caulfield, T. When Celebrity Culture and Science Clash: The Twisting of Research and Health Policy. Baker Institute of Public Policy. Rice University. Houston, TX. Mar 2015.
McCabe, C. Value Engineered Translation. Alberta Health Services Lunch and Learn. Mar 2015.
McCabe, C. Why I Hate MCDA. UBC Centre for Health Services and Policy Research Conference. Vancouver, BC. Mar 2015.
Caulfield, T. When Celebrity Culture and Science Clash: The Distortion of Independent Research. Olivieri Lectureship on Medical Ethics. University of Alberta. Edmonton, AB. Jan 2015.
McCabe, C. What has Health Economics ever done for the NHS? UK Health Economics Study Group Conference. Leeds, UK. Jan 2015.
2014
Paulden, M. Transforming the Cost-effectiveness Threshold into a ‘Value Threshold’: Initial Findings from a Simulation Model. NICE and the cost-effectiveness thresholds: Can good intentions compensate for bad practice? University College London. London, UK. Dec 2014.
McCabe, C. The Risks of Reactive Translation: a case study. Regenerative Medicines Translation – a pathway into clinical practice. University of Alberta, UK NICE and Cell Catapult. London, UK. Dec 2014.
McCabe, C; Bubela, T. Translational Research for Reimbursement: The Value Engineered Translation Framework. Regenerative Medicine Translation – a pathway into clinical practice. [invited speakers and workshop co-organizers]. University of Alberta, UK NICE and Cell Catapult. London, UK. Dec 2014.
Bubela, T. Technology Landscaping to Support Value Engineered Translation. Methods to Support Regenerative Medicine Translation. Regenerative Medicines Translation – a pathway into clinical practice. University of Alberta, UK NICE and Cell Catapult. London, UK. Dec 2014.
Bubela, T. Traversing the 3 Rs: Regeneration, Regulation, & Reimbursement. London Regenerative Medicine Network. London, UK. Dec 2014.
Paulden, M. Do Social Values Transform the Value-Based Translational Calculus for Regenerative Medicine? Driving Regenerative Medicine to the Market and Clinic. Toronto, ON. Nov 2014.
McCabe, C; Bubela, T. Addressing Barriers to Clinical Translation of Regenerative Medicine. Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments and Ethical-Legal Challenges. Toronto, ON. Nov 2014.
Caulfield, T. Introductory Comments, Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments, and Ethical-Legal Challenges. Toronto, ON. Nov 2014.
Caulfield, T. The Obesity Gene and the Misplaced Search for a Personalized Approach to or Weight Gain Problems. Centre for Law and Biosciences Workshop. Stanford University, CA. Nov 2014.
Paulden, M. The Lambda Complex: Knowing Your Place In The Threshold Matrix (Poster). 36th Annual Meeting of the Society for Medical Decision Making. Miami, FL. Oct 2014.
Caulfield, T. The Cure for Everything: The Forces that Twist – What We Hear About Science and Health. CSACI Annual Scientific Meeting. Ottawa, ON. Oct 2014.
Caulfield, T. Genome Research and Translation: The Hope, Harm and Confusion. Po-Gen Seminar on Genetics and Health Care. University of Ireland. Oct 2014.
Caulfield, T. Is Personalized Medicine Really the Answer? Mapping the Benefits and Limits of Using Genetic Testing to Improve Your Health. Reykjavik, Iceland. Oct 2014.
McCabe, C. Beyond the Cookie-cutter: Choosing what to Pay for in the Era of Patient Centred Care. Canadian Health Policy Assembly. Banff, AB. Oct 2014.
Akude, P. Poster Presentation: Advancing Methods of HTA: Optimising Monitoring Tests to Meet Value Targets. Society for Medical Decision Making (SMDM) Conference. Miami, FL. Oct 2014.
Paulden, M. Do Social Values Transform the Value-Based Translational Calculus for Regenerative Medicine? Commercialization Workshop. University of Alberta and Stem Cell Network. Toronto, ON. Oct 2014.
McCabe, C. Value Engineered Translation: Stem Cell Therapies in Diabetes. VET CASE Study. Commercialization Workshop. University of Alberta and Stem Cell Network. Toronto, ON. Oct 2014. Ottawa, ON. Oct 2014.
McCabe, C. Gearing Clinical Studies for Reimbursement Success. Till and McCullogh: CCRM fringe event. Ottawa, ON. Oct 2014.
McCabe, C. Health Economics and Clinical Translation of Stem Cell Technologies. Till and McCullogh Clinical Trials Reimbursement. Ottawa, ON. Oct 2014.
Akude, P. Advancing Methods of HTA: Optimising Monitoring Tests to Meet Value Targets (poster). SMDM. Miami, Florida. Oct 2014.
McCabe, C. Time to Stop Paying for Lemons: Linking Payment to Results for Medical Technologies. CADTH 25th Anniversary Lecture. Ottawa, ON. Sept 2014.
Caulfield, T. Twisting the Truth?: An Exploration of the Forces that Distort what we Hear and Believe About What Makes Us Healthy. Basel, Switzerland. Aug 2014.
Zarzecny, Z. Personalized Medicine: Altering the Role of Medical Necessity in Health System Policy. International Political Science Association Conference. Montreal, Qc. Jul 2014.
Bubela, T. Intellectual Property and the Mouse Commons. The Network for Bodies, Organs and Tissues (NBOT) Inaugural Annual Symposium. Faculty of Law, University of Sydney, Sydney, Australia. Jul 2014.
Bubela, T. Cost Effective Therapeutic Development of Regenerative Medicine. Leading or Limping?: Regulation in the Age of Personalised Medicine. University of Tasmania, Australia. Jul 2014.
Caulfield, T. Regulation and Personalized Medicine: Focusing Reform. Leading or Leaping?: Regulation in the Age of Personalized Medicine. University of Tasmania, Australia. Jul 2014.
Caulfield, T. Health Myths and the Forces that Twist. Inaugural Ethics, Law and Society Lecture. University of Adelaide, Australia. Jul 2014.
Zarzecny A. Personalized Medicine: Altering the Role of Medical Necessity in Health System Policy. International Political Science Association Conference. Montreal, Qc. Jul 2014.
Pillay JF, Stafinski T, Menon D. Public input for Supporting Policy Development for Pharmacogenomics: A Scoping Review. Poster presentation at the 2014 Annual Conference of Health Technology Assessment International. Washington DC. Jun 2014.
McCabe, C. Commercialisation for Value Based Market Access. Centre for Commercialization of Regenerative Medicine. Toronto, ON. Jun 2014.
Gold ER. PACEOMICS: Personalized, Accessible, Cost-Effective ‘Omics Technologies. Sommet sur les Soins de Santé Personnalisées. Montreal, Qc. Jun 2014.
Kamenova K. Celebrity Medicine and the Media: Newspaper Coverage of Angelina Jolie’s Preventative Mastectomy. Canadian Communication Association Annual Meeting. St Catherines, ON. May 2014.
Caulfield T. Health Myths and Science Hype: Why all the Confusion? Biology and Chemistry Regionals Annual Conference. Edmonton, AB. May 2014.
Caulfield T. From Celebrities to Science Hype: Twisting the Truth About Healthy Living. Wake Forest Journal of Law and Policy Annual Symposium. Winston-Salem, North Carolina. April 2014.
Caulfield T. Who Controls Your Genes, Cells and Tissue? Institute for Values in Policy and Science, Simon Fraser University. Burnaby, BC. Mar 2014.
Caulfield T. Science Hype. Presidential Commission for the Study of Bioethical Issues. Washington DC. Feb 2014.
Caulfield T. Genohype: Implications for Policy and Guideline Development. Primary Care Genomics: Peter Wall Institute For Advanced Studies Workshop, University of British Columbia. Vancouver, BC. Feb 2014.
Caulfield T. The Policy Challenges and Health Limits of Personalized Medicine. Peter Wall Institute for Advanced Studies, University of British Columbia. Vancouver, BC. Feb 2014.
Caulfield T. Biotechnology and the Media. Regenerative Medicine, Institute of Medical Science, University Health Network, Toronto, ON. Feb 2014.
2013
Gold ER. A World of Confusion: Patent Law and the Life Sciences. Canadian Science Policy Conference. Toronto, ON. Nov 2013.
Gold ER. Myriad and Beyond: The Fallout of the US Supreme Court Decision. Science and Technology Studies Colloquium. Vancouver, BC, Nov 2013.
Bubela T. Collaborative Mechanisms for the Clinical Translation of Stem Cell Therapies in a Global Environment. University of Wisconsin Law School. Madison, WI. Oct 2013.
McCabe C. Personalized Medicine: a Testing Evaluation. CSPS Conference. Vancouver, BC. May 2013.
Bubela T. Commercialization and Translational Challenges for Whole Genome Sequencing. Exploring the unique social/ ethical and health system challenges of low cost whole genome sequencing. CIHR Institute of Genetics, Montreal, Qc. Apr 2013.
Caulfield T. Reexamining the Promise and Perils of Personalized Medicine: Patents and Beyond. Genes & Diagnostics: A Myriad of Issues. Keynote address. Cold Spring Harbor Laboratory, New York, Mar 2013.
Caulfield T. The Genetic ‘Revolution’ and Personalized Healthcare: Why We Shouldn’t Hold Our Breadth. Presentation at McMaster University Health Forum, Hamilton, ON, Jan 2013.